| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.341 | 0.003 | 0.341 | Acetylcholine release stimulant | 0.109 0.069 CID_154699884 | ||
| 0.322 | 0.041 | 0.412 | Vasodilator | 0.412 0.021 CID_154699884 | CID_154699884 | |
| 0.383 | 0.116 | 0.383 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.258 | 0.027 | 0.258 | Cholinergic | |||
| 0.309 | 0.127 | 0.309 | MAP kinase kinase 6 inhibitor | |||
| 0.179 | 0.002 | 0.179 | Nitric oxide donor | 0.13 0.003 CID_154699884 | ||
| 0.172 | 0.012 | 0.172 | CYP2A6 inhibitor | |||
| 0.15 | 0.008 | 0.15 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.23 | 0.103 | 0.23 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.128 | 0.005 | 0.128 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.215 | 0.102 | 0.215 | Superoxide dismutase inhibitor | |||
| 0.168 | 0.058 | 0.168 | NOS3 expression enhancer | 0.162 0.062 CID_154699884 | ||
| 0.12 | 0.026 | 0.12 | Acetylcholine nicotinic agonist | |||
| 0.193 | 0.102 | 0.193 | Nitric-oxide synthase stimulant | |||
| 0.118 | 0.031 | 0.118 | Acetylcholine nicotinic antagonist | |||
| 0.202 | 0.116 | 0.202 | MAP kinase kinase 3 inhibitor | |||
| 0.108 | 0.021 | 0.108 | Neuronal nicotinic receptor antagonist | |||
| 0.091 | 0.009 | 0.091 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.128 | 0.049 | 0.128 | 5 Hydroxytryptamine 3A agonist | |||
| 0.204 | 0.128 | 0.204 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.086 | 0.015 | 0.086 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.069 | 0.003 | 0.069 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.071 | 0.01 | 0.071 | Glycine transporter 1 inhibitor | |||
| 0.078 | 0.022 | 0.078 | Nicotinic neuronal receptor agonist | |||
| 0.213 | 0.161 | 0.26 | Vasodilator, peripheral | 0.26 0.12 CID_154699884 | CID_154699884 | |
| 0.226 | 0.177 | 0.226 | GABA C receptor rho-3 antagonist | |||
| 0.053 | 0.004 | 0.053 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.054 | 0.014 | 0.054 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.065 | 0.027 | 0.065 | Nicotinic alpha7 receptor agonist | |||
| 0.221 | 0.184 | 0.221 | Calcium channel activator | |||
| 0.033 | 0.004 | 0.033 | Nicotinic alpha4 receptor agonist | |||
| 0.122 | 0.094 | 0.122 | Activin receptor-like kinase 2 inhibitor | |||
| 0.046 | 0.023 | 0.046 | Nerve growth factor antagonist | |||
| 0.061 | 0.039 | 0.061 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.083 | 0.062 | 0.083 | Acetylcholine agonist | |||
| 0.094 | 0.074 | 0.094 | GABA C receptor agonist | |||
| 0.033 | 0.014 | 0.033 | DNA topoisomerase IV inhibitor | |||
| 0.062 | 0.045 | 0.062 | 5 Hydroxytryptamine 3 agonist | |||
| 0.126 | 0.109 | 0.126 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.045 | 0.029 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.175 | 0.161 | 0.459 | DNA synthesis inhibitor | 0.459 0.016 CID_154699884 | CID_154699884 | |
| 0.08 | 0.068 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.139 | 0.127 | 0.146 | Psychostimulant | 0.146 0.12 CID_154699884 | CID_154699884 | |
| 0.121 | 0.11 | 0.121 | Death-associated protein kinase 1 inhibitor | |||
| 0.248 | 0.256 | 0.276 | Caspase 9 stimulant | 0.276 0.221 CID_154699884 | CID_154699884 | |
| 0.111 | 0.122 | 0.124 | Acetylcholine M1 receptor antagonist | 0.124 0.102 CID_154699884 | CID_154699884 | |
| 0.091 | 0.117 | 0.114 | Alpha-N-acetylglucosaminidase inhibitor | 0.114 0.084 CID_154699884 | CID_154699884 | |
| 0.035 | 0.093 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.027 CID_154699884 | CID_154699884 | |
| 0.178 | 0.239 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.18 CID_154699884 | CID_154699884 | |
| 0.022 | 0.087 | 0.051 | Guanylate cyclase inhibitor | 0.051 0.02 CID_154699884 | CID_154699884 | |
| 0.093 | 0.179 | 0.21 | Insulin secretagoues | 0.21 0.031 CID_154699884 | CID_154699884 | |
| 0.083 | 0.215 | 0.161 | DNA repair enzyme inhibitor | 0.161 0.023 CID_154699884 | CID_154699884 | |
| 0.021 | 0.172 | 0.067 | Carbamoyl phosphate synthetase inhibitor | 0.067 0.037 CID_154699884 | CID_154699884 | |
| 0.021 | 0.176 | 0.118 | Biliverdin reductase inhibitor | 0.118 0.014 CID_154699884 | CID_154699884 | |
| 0.045 | 0.208 | 0.242 | UDP-glucose 4-epimerase inhibitor | 0.242 0.014 CID_154699884 | CID_154699884 | |
| 0.018 | 0.181 | 0.078 | Argininosuccinate synthase inhibitor | 0.078 0.026 CID_154699884 | CID_154699884 | |
| 0.125 | 0.292 | 0.399 | Vasodilator, coronary | 0.399 0.036 CID_154699884 | CID_154699884 | |
| 0.009 | 0.181 | 0.034 | Fumarate hydratase inhibitor | 0.034 0.024 CID_154699884 | CID_154699884 | |
| 0.061 | 0.234 | 0.365 | Angiogenesis stimulant | 0.365 0.029 CID_154699884 | CID_154699884 | |
| 0.099 | 0.278 | 0.248 | Cyclic AMP phosphodiesterase inhibitor | 0.248 0.064 CID_154699884 | CID_154699884 | |
| 0.109 | 0.29 | 0.301 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.301 0.023 CID_154699884 | CID_154699884 | |
| 0.018 | 0.202 | 0.128 | Phosphofructokinase-1 inhibitor | 0.128 0.023 CID_154699884 | CID_154699884 | |
| 0.137 | 0.322 | 0.47 | Antibacterial | 0.47 0.05 CID_154699884 | CID_154699884 | |
| 0.044 | 0.233 | 0.148 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.148 0.027 CID_154699884 | CID_154699884 | |
| 0.006 | 0.211 | 0.02 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.02 0.006 CID_154699884 | CID_154699884 | |
| 0.032 | 0.238 | 0.109 | Glutamate dehydrogenase inhibitor | 0.109 0.027 CID_154699884 | CID_154699884 | |
| 0.042 | 0.249 | 0.127 | Alkylator | 0.127 0.062 CID_154699884 | CID_154699884 | |
| 0.054 | 0.272 | 0.115 | Adenylate kinase inhibitor | 0.115 0.048 CID_154699884 | CID_154699884 | |
| 0.067 | 0.287 | 0.199 | Interleukin agonist | 0.199 0.122 CID_154699884 | CID_154699884 | |
| 0.041 | 0.283 | 0.105 | NADH dehydrogenase inhibitor | 0.105 0.039 CID_154699884 | CID_154699884 | |
| 0.126 | 0.371 | 0.282 | Interleukin 2 agonist | 0.282 0.087 CID_154699884 | CID_154699884 | |
| 0.103 | 0.35 | 0.209 | RNA-directed DNA polymerase inhibitor | 0.209 0.087 CID_154699884 | CID_154699884 | |
| 0.102 | 0.357 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.117 CID_154699884 | CID_154699884 | |
| 0.087 | 0.38 | 0.25 | Antithrombotic | 0.25 0.126 CID_154699884 | CID_154699884 | |
| 0.074 | 0.373 | 0.24 | Transcription factor NF kappa B inhibitor | 0.24 0.135 CID_154699884 | CID_154699884 | |
| 0.023 | 0.323 | 0.118 | Histone deacetylase stimulant | 0.118 0.018 CID_154699884 | CID_154699884 | |
| 0.023 | 0.323 | 0.118 | Histone deacetylase SIRT1 stimulant | 0.118 0.018 CID_154699884 | CID_154699884 | |
| 0.018 | 0.355 | 0.104 | Expectorant | 0.104 0.064 CID_154699884 | CID_154699884 | |
| 0.035 | 0.417 | 0.114 | Aldehyde dehydrogenase inhibitor | 0.114 0.077 CID_154699884 | CID_154699884 | |
| 0.004 | 0.406 | 0.042 | Adenosine A1 receptor agonist | 0.042 0.007 CID_154699884 | CID_154699884 | |
| 0.077 | 0.517 | 0.254 | Apoptosis antagonist | 0.254 0.124 CID_154699884 | CID_154699884 | |
| 0.012 | 0.459 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 CID_154699884 | CID_154699884 | |
| 0.025 | 0.498 | 0.238 | Immunostimulant | 0.238 0.101 CID_154699884 | CID_154699884 | |
| 0.03 | 0.508 | 0.25 | DNA methyltransferase I inhibitor | 0.25 0.047 CID_154699884 | CID_154699884 | |
| 0.029 | 0.543 | 0.25 | DNA methylase inhibitor | 0.25 0.048 CID_154699884 | CID_154699884 | |
| 0.08 | 0.606 | 0.356 | Peptidyltransferase inhibitor | 0.356 0.011 CID_154699884 | CID_154699884 | |
| 0.003 | 0.534 | 0.031 | Purinergic P2X agonist | 0.031 0.017 CID_154699884 | CID_154699884 | |
| 0.02 | 0.569 | 0.175 | Free radical scavenger | 0.175 0.119 CID_154699884 | CID_154699884 | |
| 0.029 | 0.701 | 0.209 | Hepatoprotectant | 0.209 0.06 CID_154699884 | CID_154699884 | |
| 0.008 | 0.691 | 0.062 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 CID_154699884 | CID_154699884 | |
| 0.011 | 0.694 | 0.156 | Platelet antagonist | 0.156 0.138 CID_154699884 | CID_154699884 | |
| 0.006 | 0.726 | 0.2 | Topoisomerase I inhibitor | 0.2 0.026 CID_154699884 | CID_154699884 | |
| 0.018 | 0.815 | 0.216 | Hypoglycemic | 0.216 0.099 CID_154699884 | CID_154699884 | |
| 0.015 | 0.825 | 0.213 | Immunosuppressant | 0.213 0.183 CID_154699884 | CID_154699884 | |
| 0.019 | 0.867 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.073 CID_154699884 | CID_154699884 | |
| 0.013 | 0.862 | 0.242 | Apoptosis agonist | 0.242 0.223 CID_154699884 | CID_154699884 | |
| 0.005 | 0.855 | 0.163 | Antioxidant | 0.163 0.15 CID_154699884 | CID_154699884 | |
| 0.006 | 0.862 | 0.039 | Purinergic P2Y2 antagonist | 0.039 0.017 CID_154699884 | CID_154699884 | |
| 0.001 | 0.879 | 0.018 | Purinergic P2 agonist | 0.018 0.008 CID_154699884 | CID_154699884 | |
| 0.001 | 0.879 | 0.018 | Purinergic receptor agonist | 0.018 0.008 CID_154699884 | CID_154699884 | |
| 0.003 | 0.882 | 0.02 | Adenosine A3 receptor agonist | 0.02 0.009 CID_154699884 | CID_154699884 | |
| 0.001 | 0.891 | 0.013 | Purinergic P2Y agonist | 0.013 0.008 CID_154699884 | CID_154699884 | |
| 0.013 | 0.904 | 0.197 | DNA polymerase I inhibitor | 0.197 0.029 CID_154699884 | CID_154699884 | |
| 0.004 | 0.914 | 0.102 | Aminoacyl-tRNA synthetase inhibitor | 0.102 0.043 CID_154699884 | CID_154699884 | |
| 0.007 | 0.937 | 0.197 | Immunomodulator | 0.197 0.168 CID_154699884 | CID_154699884 | |
| 0.002 | 0.956 | 0.015 | Adenosine A2b receptor agonist | 0.015 0.009 CID_154699884 | CID_154699884 | |
| 0.006 | 0.964 | 0.141 | Platelet adhesion inhibitor | 0.141 0.116 CID_154699884 | CID_154699884 | |
| 0.005 | 0.98 | 0.27 | Cyclophilin D inhibitor | 0.27 0.19 CID_154699884 | CID_154699884 | |
| 0.007 | 0.986 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 CID_154699884 | CID_154699884 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |